The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines

被引:9
作者
Lambert, PA [1 ]
Kang, Y [1 ]
Greaves, B [1 ]
Perry, RR [1 ]
机构
[1] Eastern Virginia Med Sch, Dept Surg, Div Surg Oncol, Norfolk, VA 23507 USA
关键词
mitomycin C; drug resistance; glutathione; colon cancer; DT-diaphorase; p-glycoprotein;
D O I
10.1006/jsre.1998.5481
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Prior studies have suggested the multifactorial nature of mitomycin C (MMC) resistance. However, the relative importance of the different resistance mechanisms is unknown, Materials and methods. A panel of colon cancer cell lines with levels of MMC resistance from 2- to 15-fold compared to the parent line MT-29 was produced by repeated MMC exposure. Cell survival was measured using clonogenic assay, Glutathione and related enzymes and DT-diaphorase were measured using biochemical assays. P-glycoprotein expression was measured using flow cytometry. Topoisomerase II activity was measured using the pBR322 DNA relaxation assay. Results. Multiple drug resistance mechanisms were altered in the resistant cell lines (glutathione reductase, glutathione peroxidase, topoisomerase II). However, the level of DT-diaphorase correlated best with the degree of MMC resistance. The importance of DT-diaphorase was confirmed by using BMY 25282, an MMC analogue which is less dependent on DT-diaphorase for activation, Resistance in the HT-29R54 cell line was 15-fold with MMC compared to B-fold with BMY 25282, P-glycoprotein-mediated resistance does not appear important in this model. Conclusions. Although MMC resistance appears to be multifactorial, the results of this study strongly suggest that DT-diaphorase is the major contributor to MMC resistance under aerobic conditions. Strategies to enhance drug activation may therefore be useful for reversing MMC resistance, (C) 1998 Academic Press.
引用
收藏
页码:177 / 181
页数:5
相关论文
共 28 条
[1]  
BEGLEITER A, 1992, MOL PHARMACOL, V41, P677
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
Brattain M G, 1986, Prog Clin Biol Res, V223, P63
[4]   GLUTATHIONE AND RELATED ENZYME-ACTIVITY IN HUMAN-LUNG CANCER CELL-LINES [J].
CARMICHAEL, J ;
MITCHELL, JB ;
FRIEDMAN, N ;
GAZDAR, AF ;
RUSSO, A .
BRITISH JOURNAL OF CANCER, 1988, 58 (04) :437-440
[5]  
CHAKRABARTY S, 1986, CANCER RES, V46, P3456
[6]   MITOMYCIN-C - REVIEW [J].
CROOKE, ST ;
BRADNER, WT .
CANCER TREATMENT REVIEWS, 1976, 3 (03) :121-139
[7]  
ERNESTER L, 1967, METHOD ENZYMOL, V10, P309
[8]  
FORREST GL, 1990, BIOCHEM BIOPH RES CO, V193, P1087
[9]  
HABIG WH, 1974, J BIOL CHEM, V249, P7130
[10]   REDUCED TOPOISOMERASE-II AND ELEVATED ALPHA CLASS GLUTATHIONE-S-TRANSFERASE EXPRESSION IN A MULTIDRUG RESISTANT CHO CELL-LINE HIGHLY CROSS-RESISTANT TO MITOMYCIN-C [J].
HOBAN, PR ;
ROBSON, CN ;
DAVIES, SM ;
HALL, AG ;
CATTAN, AR ;
HICKSON, ID ;
HARRIS, AL .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (04) :685-693